Evotec SE (EVO) Profit After Tax Growth (3y) (2022 - 2025)
Powered by 
Analysis
Evotec SE (EVO) Profit After Tax Growth (3y) (2022 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | -4.58% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 25.73% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | -26.30% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | -12.42% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | -34.12% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 30.84% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 35.35% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 6.62% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 953.92% |
| Sep 30, 2025 | -45.13% |
| Jun 30, 2025 | -917.89% |
| Mar 31, 2025 | -639.30% |
| Dec 31, 2024 | -5.22% |
| Sep 30, 2024 | -31.52% |
| Jun 30, 2024 | -1,059.93% |
| Mar 31, 2024 | -608.26% |
| Dec 31, 2023 | 461.10% |
| Dec 31, 2022 | -26.05% |